Deleted in Azoospermia-Like (DAZL) (C-Term) Peptide
Quick Overview for Deleted in Azoospermia-Like (DAZL) (C-Term) Peptide (ABIN8098742)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- DAZL Peptide - C-terminal region
-
Sequence
- PPSGNGPQKK SVDRSIQTVV SCLFNPENRL RNSVVTQDDY FKDKRVHHFR
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-DAZL Antibody (ARP40355_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DAZL (Deleted in Azoospermia-Like (DAZL))
-
Background
-
Background Information: DAZ (Deleted in AZoospermia) is the potential RNA binding proteins that are expressed in prenatal and postnatal germ cells of males and females. DAZL is localized to the nucleus and cytoplasm of fetal germ cells and to the cytoplasm of developing oocytes. In the testis, this protein is localized to the nucleus of spermatogonia but relocates to the cytoplasm during meiosis where it persists in spermatids and spermatozoa. Transposition and amplification of the autosomal gene encoding DAZL during primate evolution gave rise to the DAZ gene cluster on the Y chromosome. Mutations in the Dazl gene have been linked to severe spermatogenic failure and infertility in males.
Alternative Symbols: DAZL
-
Molecular Weight
- 32kDa
-
Gene ID
- 1618
-
NCBI Accession
- NP_001342
-
UniProt
- Q92904
Target
-